Install
Cell & Gene Therapies
CAR‑T, CRISPR, in vivo delivery, manufacturing, and long‑term follow‑up.
- 4 Tracked terms
- Last 30 days Feed window
What this topic collects on
An article joins this feed when it matches these terms. Each one is also a search of its own.
Related topics
Latest in Cell & Gene Therapies
David Moreno on ATALANTA-1: 7-Day Vein to Vein, but Does Fresh CAR-T Add Value?
5+ hour, 44+ min ago (119+ words) David Moreno, Director of Translational Cell Sciences at UCB, shared on LinkedIn: “The conclusions of fresh CAR-T delivery clinical study ATALANTA-1 are out. 7-days vein to vein achieved but CAR-T manufacturing remains challenging, has risks associated and the added value…...
Trial Shows a Single Dose of an Experimental Therapy Reduces Lipoprotein(a), an Important Heart Disease Risk Factor, More than 94% for Nearly a Year
5+ hour, 52+ min ago (549+ words) Posted by cfelixcpa | Nov 14, 2023 | SF STAT! | 0 | First in-human trial of novel therapy was presented at the American Heart Association’s Scientific Sessions 2023 November 12, 2023 – Findings from a phase 1 trial reported by a Cleveland Clinic physician show that a single dose of an…...
Scientists Create First Hypoallergenic Gene-Edited Dogs
7+ hour, 33+ min ago (194+ words) The European Times They âswitched offâ the gene responsible for producing the primary allergen found in dog saliva, fur, and dander To create the two dogs, scientists edited the gene responsible for producing the main allergenic protein in dogs…...
Nepal begins CAR T-cell therapy for cancer patients
1+ day, 6+ hour ago (623+ words) Nepal has started treating cancer patients with locally manufactured genetically engineered cells for the first time. This marks a breakthrough in the country’s cancer treatment capabilities, doctors involved in the treatment say. A 20-year-old woman with relapsed acute lymphoblastic leukaemia,…...
Innovation in CAR T-Cell Therapy: Making Treatment Faster and More Accessible
11+ hour, 1+ min ago (522+ words) October 12, 2026 | Monday | Features The science behind car t-cell therapy has already been proven. What's harder now is the logistics side of things; actually getting this treatment to more patients, faster, without the process turning into a barrier of its own....
Donor-Derived CD19 CAR-T Cells Deliver Lasting Remissions in Leukemia Patients After Transplant Failure
5+ hour, 26+ min ago (806+ words) Bioengineer.org...
New Recommendations Released for CAR T-Cell Therapy for Autoimmune Disease
10+ hour, 6+ min ago (181+ words) An international panel has released updated guidelines for chimeric antigen receptor (CAR) T-cell therapy for autoimmune disease. The recommendations were originally released in 2024 and are coordinated by the European Society for Blood and Marrow Transplantation (EBMT), the International Society for…...
Caribou Halts Allogeneic CAR T Programs as Funding Pressures Mount
19+ hour, 47+ min ago (445+ words) Caribou Biosciences plans to discontinue its two allogeneic CAR T-cell therapy programs and make substantial workforce reductions after struggling to secure the funding needed to continue their development. The company’s board has begun a review of strategic alternatives, which could…...
Swedish decision on rival CAR-T therapies: Yes to Yescarta, no to Breyanzi
13+ hour, 57+ min ago (95+ words) Here you can administrate your corporate solutions users. Welcome to our Corporate client solution Your IP is registered with the company mentioned above and provides access to Life Science Focus. Follicular lymphoma is a type of non-Hodgkin lymphoma, a cancer…...
Nepal Treats First Cancer Patient With Locally Made CAR-T Cells
15+ hour, 26+ min ago (453+ words) KATHMANDU, October 11 – Nepal has treated a cancer patient with locally developed and manufactured CAR-T cells for the first time, marking a milestone in the country’s advanced cancer treatment capabilities. The treatment was administered on September 27 at Tribhuvan University Teaching Hospital…...